Cellectar Biosciences, Inc. · NASDAQ:CLRB
Empery Asset Management, LP reported a 9.99% stake in Cellectar Biosciences, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 4, 2026
Empery Asset Management, LP reported a 9.99% stake in Cellectar Biosciences, Inc., 864,090 shares, as a passive investor on Jun 30, 2026. Filed Aug 4, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 864,090
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Empery Asset Management, LP | 9.99% | 864,090 |
| Ryan M. Lane | 9.99% | 864,090 |
Source
Related
- Cellectar Biosciences, Inc.
- Empery Asset Management, LP
- Cellectar Biosciences, Inc. shareholders
- Schedule 13G · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · Silverarc Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Bleichroeder LP · Aug 13, 2026